Kangji Medical Holdings Limited Share Price

Equities

9997

KYG5215A1004

Medical Equipment, Supplies & Distribution

Market Closed - Hong Kong S.E. 01:38:05 31/05/2024 pm IST 5-day change 1st Jan Change
6.02 HKD -1.47% Intraday chart for Kangji Medical Holdings Limited -22.72% -13.88%

Financials

Sales 2024 * 1.13B 157M 1.22B 13.06B Sales 2025 * 1.34B 186M 1.45B 15.49B Capitalization 6.77B 935M 7.31B 77.98B
Net income 2024 * 569M 78.58M 615M 6.55B Net income 2025 * 669M 92.39M 723M 7.71B EV / Sales 2024 * 4.67 x
Net cash position 2024 * 1.48B 204M 1.6B 17.02B Net cash position 2025 * 2.07B 286M 2.24B 23.85B EV / Sales 2025 * 3.49 x
P/E ratio 2024 *
11.7 x
P/E ratio 2025 *
9.97 x
Employees 1,002
Yield 2024 *
4.29%
Yield 2025 *
5.02%
Free-Float 29.52%
More Fundamentals * Assessed data
Dynamic Chart
Kangji Medical Holdings Limited commences an Equity Buyback Plan for 121,482,100 shares, representing 10% of its issued share capital, under the authorization approved on May 27, 2024. CI
Kangji Medical Holdings Limited Approves Special Dividend for the Year Ended 31 December 2023, Payable on 18 July 2024 CI
Kangji Medical Holdings Limited Approves Final Dividend for the Year Ended December 31, 2023, Payable on 18 July 2024 CI
Kangji Medical Holdings Limited's Equity Buyback announced on December 27, 2023, has expired. CI
Kangji Medical Holdings Limited Proposes Special Dividend for the Year Ended December 31, 2023 CI
Kangji Medical Holdings' Profit Rises 5% in 2023 MT
Kangji Medical Holdings Limited Proposes Special Dividend for the year ended December 31, 2023, Payable on 18 July 2024 CI
Kangji Medical Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Kangji Medical Holdings Limited Proposes Final Dividend for the Year Ended December 31, 2023, Payable on 18 July 2024 CI
Kangji Medical Holdings Unit Offloads Stake in Medical Instrument Company MT
Kangji Medical Holdings Limited commences an Equity Buyback Plan for 121,679,200 shares, representing 10% of its issued share capital, under the authorization approved on May 25, 2023. CI
Kangji Medical Holdings Limited initiates a Market Repurchase. CI
Kangji Medical Holdings Limited Announces CFO Changes CI
Kangji Medical Holdings Limited Announces the Resignation of Frances Fang Chovanec as Executive Director, Member of Environmental, Social and Governance Committee with Effective from September 15, 2023 CI
Kangji Medical Holdings Limited Reports Earnings Results for the Half Year Ended June 30, 2023 CI
More news
1 day-1.47%
1 week-22.72%
1 month-17.98%
3 months-9.61%
6 months-18.21%
Current year-13.88%
More quotes
1 week
5.96
Extreme 5.96
8.07
1 month
5.96
Extreme 5.96
8.20
Current year
5.71
Extreme 5.71
8.20
1 year
5.71
Extreme 5.71
8.92
3 years
5.28
Extreme 5.28
14.42
5 years
5.28
Extreme 5.28
35.65
10 years
5.28
Extreme 5.28
35.65
More quotes
Managers TitleAgeSince
Chief Executive Officer 49 01/04/01
Director of Finance/CFO 47 15/23/15
Chief Tech/Sci/R&D Officer 44 16/09/16
Members of the board TitleAgeSince
Director/Board Member 61 07/20/07
Director/Board Member 67 07/20/07
Director/Board Member 40 13/20/13
More insiders
Date Price Change Volume
31/24/31 6.02 -1.47% 1,420,500
30/24/30 6.11 +1.50% 1,642,500
29/24/29 6.02 -23.80% 3,432,500
28/24/28 7.9 -0.13% 1,612,500
27/24/27 7.91 +1.54% 1,540,000

Delayed Quote Hong Kong S.E., May 31, 2024 at 01:38 pm IST

More quotes
Kangji Medical Holdings Ltd is a China-based investment holding company mainly engaged in the design, development, manufacture and sale of minimally invasive surgical instruments and accessories. The Company's main products include disposable trocars, polymer ligation clips, disposable electrocoagulation forceps and other disposable products, which are used in gynecology and obstetrics, urology, general surgery and thoracic surgery. The Company distributes its products within the domestic market and to overseas markets.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
5.575 CNY
Average target price
9.274 CNY
Spread / Average Target
+66.36%
Consensus